What is he best known for?
The fields of study he is best known for:
- Gene
- Amino acid
- Neurotransmitter
The scientist’s investigation covers issues in Glycine receptor, Biochemistry, NMDA receptor, Neuroscience and Receptor.
His Glycine receptor research incorporates themes from Agonist, Molecular biology, Biophysics and Inhibitory postsynaptic potential.
His Biochemistry study typically links adjacent topics like Alpha.
His research in NMDA receptor tackles topics such as Glycine binding which are related to areas like Ionotropic effect, Phenylalanine and Glutamate receptor.
His work focuses on many connections between Neuroscience and other disciplines, such as Neurotransmission, that overlap with his field of interest in Drug discovery, Allosteric regulation, Nicotinic acetylcholine receptor, Ion channel and Synaptic plasticity.
The various areas that Bodo Laube examines in his Receptor study include Endocrinology, Strychnine, Hereditary hyperekplexia and Brainstem.
His most cited work include:
- Evidence for a Tetrameric Structure of Recombinant NMDA Receptors (434 citations)
- Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. (412 citations)
- Loss of Postsynaptic GABAA Receptor Clustering in Gephyrin-Deficient Mice (390 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Glycine receptor, Biochemistry, NMDA receptor, Protein subunit and Biophysics.
His Glycine receptor study necessitates a more in-depth grasp of Glycine.
His NMDA receptor research is multidisciplinary, incorporating elements of Glutamate receptor and Glycine binding.
He combines subjects such as Xenopus, Transmembrane protein, Wild type, Transmembrane domain and Cell biology with his study of Protein subunit.
His Biophysics study integrates concerns from other disciplines, such as Long-term potentiation and Cys-loop receptors.
In his research, Neurotransmission is intimately related to Neuroscience, which falls under the overarching field of Receptor.
He most often published in these fields:
- Glycine receptor (63.55%)
- Biochemistry (47.66%)
- NMDA receptor (35.51%)
What were the highlights of his more recent work (between 2013-2021)?
- Biophysics (39.25%)
- Glutamate receptor (14.95%)
- NMDA receptor (35.51%)
In recent papers he was focusing on the following fields of study:
Bodo Laube mainly focuses on Biophysics, Glutamate receptor, NMDA receptor, Receptor and Protein subunit.
His research in Biophysics intersects with topics in Agonist, AMPA receptor and Glycine receptor.
The Agonist study combines topics in areas such as Glycine and Ion channel.
His biological study spans a wide range of topics, including Neuroscience and Cys-loop receptors.
Glutamate receptor is a subfield of Biochemistry that Bodo Laube tackles.
Bodo Laube does research in NMDA receptor, focusing on Memantine specifically.
Between 2013 and 2021, his most popular works were:
- GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. (131 citations)
- GRIN2B encephalopathy : Novel findings on phenotype, variant clustering, functional consequences and treatment aspects (84 citations)
- Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy (82 citations)
In his most recent research, the most cited papers focused on:
Bodo Laube focuses on Intellectual disability, Autism, Epilepsy, Chloride channel and Ligand-gated ion channel.
His Intellectual disability study incorporates themes from Mutation, Consanguinity, Phenotype and GRIN1.
His work deals with themes such as GRIN2B, Encephalopathy and Pediatrics, which intersect with Epilepsy.
His Chloride channel research is multidisciplinary, incorporating elements of Amino acid, Postsynaptic potential, Pharmacology and Binding site.
As part of his inquiry into Biochemistry and Ion channel, Bodo Laube is doing Ligand-gated ion channel research.
The various areas that Bodo Laube examines in his Biophysics study include Agonist, Propofol, Glycine receptor and Glutamic acid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
